Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis

Clinical Respiratory Journal

Volumn 7, Issue 4, 2013, Pages 390-396

  Gulsvik, Ragnhild ^a   Skjørten, Ingunn ^a   Undhjem, Kenneth ^b   Holø, Lars ^a   Frostad, Anne ^a   Saure, Eirunn Waatevik ^b   Lejlic, Vasvija ^c   Humerfelt, Sjur ^a   Hansen, Gunnar ^a   Bruun Wyller, Torgeir ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c SSHF   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Acetazolamide; Chronic obstructive pulmonary disease; Hypoxia; Metabolic alkalosis; Respiratory failure

Indexed keywords

ACETAZOLAMIDE; CARBON DIOXIDE; PLACEBO;

AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HEADACHE; HOSPITAL PATIENT; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC ALKALOSIS; NAUSEA; OXYGENATION; PARALLEL DESIGN; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SHORT COURSE THERAPY; TASTE DISORDER; THORAX PAIN;

ACETAZOLAMIDE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; HYPOXIA; METABOLIC ALKALOSIS; RESPIRATORY FAILURE;

ACETAZOLAMIDE; AGED; AGED, 80 AND OVER; ALKALOSIS; ANOXIA; CARBON DIOXIDE; CARBONIC ANHYDRASE INHIBITORS; DOUBLE-BLIND METHOD; ELECTROLYTES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84884813991     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12025     Document Type: Article

References (12)

1. Kassamali R, Sica DA. Acetazolamide: a forgotten diuretic agent. Cardiol Rev. 2011;19: 276-278.
2. Teppema LJ, van Dorp ELA, Dahan A. Arterial [H+] and the ventilatory response to hypoxia in humans: influence of acetazolamide-induced metabolic acidosis. Am J Physiol Lung Cell Mol Physiol. 2010;298: 89-95.
3. Teppema LJ, Balanos GM, Steinback CD, etal. Effects on acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am J Respir Crit Care Med. 2007;175: 277-281.
4. Bales MJ, Timpe EM. Respiratory stimulant use in chronic obstructive pulmonary disease. Ann Pharmacother. 2004;38: 1722-1725.
5. Faisy C, Mokline A, Sanchez O, etal. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation. Intensive Care Med. 2010;36: 859-863.
6. Heming ND, Faisy C, Urien S. Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated COPD patients. Crit Care. 2011;15: R213.
7. DuBose TD. Acidosis and alkalosis. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine, 17th edn. New York, McGraw-Hill, 2008: 287-296.
8. Jones P, Greenstone M. Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2001;(1): CD002881 (up to date by October 26, 2010).
9. Hacki MA, Waldeck G, Brandli O. Acetazolamid bei hyperkapnischer chronischer obstruktiver Lungenkrankenheit - eine Renaissance? Schwiez Med Wochenschr. 1983;113: 110-114.
10. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323: 1123-1124.
11. van de Ven MJT, Colier WNJM, van der Sluijs MC, etal. Effects of acetazolamide and furosemide on ventilation and cerebral blood volume in normocapnic and hypercapnic patients with COPD. Chest. 2002;121: 383-392.
12. Maren TH, Mayer E, Wadsworth BC. Carbonic anhydrase inhibition. The pharmacology of Diamox 2-acetylamino-1, 3, 4-thiadiazole-5-sulfonamide. Bull Johns Hopkins Hosp. 1954;95: 199-243.